mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |